Anticandidal Agents

Anticandidal Agents provides the latest information on candida drug resistance and its remedial implications. In this compilation, users will find a comprehensive view on overcoming resistance in anticandidal drugs, along with information on novel molecules. Candida albicans is an opportunistic pathogenic fungus responsible for life threating invasive and nosocomial infections across the globe. Candidiasis is a major cause of morbidity among immunocompromised patients. Infections caused by non-albicans candida like C. glabrata, C. parapsilosis, and C. tropicalis have also imposed a serious threat in the last few decades. Current treatment of candidiasis relies primarily on antifungal agents broadly categorized as azoles, polyenes, echinocandins, allylamines, and pyrimidines. Lately, antifungal resistance has emerged to be an obstruction of current treatment regime. A number of reasons are described in detail. Understanding the mechanisms of resistance is crucial for developing strategies for overcoming the hindrance in current therapeutics. Presents a complete understanding of candida resistance to help in the development of therapeutic expansion and novel drugs Provides thorough information on candida drug resistance and its remedial implications Covers crucial mechanisms of resistance that will help develop strategies for overcoming the hindrance in current therapeutics

Produk Detail:

  • Author : Awanish Kumar
  • Publisher : Academic Press
  • Pages : 94 pages
  • ISBN : 012811312X
  • Rating : 4/5 from 21 reviews
CLICK HERE TO GET THIS BOOKAnticandidal Agents

Anticandidal Agents

Anticandidal Agents
  • Author : Awanish Kumar
  • Publisher : Academic Press
  • Release : 12 September 2016
GET THIS BOOKAnticandidal Agents

Anticandidal Agents provides the latest information on candida drug resistance and its remedial implications. In this compilation, users will find a comprehensive view on overcoming resistance in anticandidal drugs, along with information on novel molecules. Candida albicans is an opportunistic pathogenic fungus responsible for life threating invasive and nosocomial infections across the globe. Candidiasis is a major cause of morbidity among immunocompromised patients. Infections caused by non-albicans candida like C. glabrata, C. parapsilosis, and C. tropicalis have also imposed a

Antifungal Agents

Antifungal Agents
  • Author : Ernst M. Jucker
  • Publisher : Birkhäuser
  • Release : 06 December 2012
GET THIS BOOKAntifungal Agents

This second volume of PDR SPECIAL TOPICS contains five review articles, covering nearly the entire field of fungal diseases in humans as well as therapeutic approaches. The main emphasis of the book lies in antifungal therapy: the most relevant information on the present state of the art of antifungal chemotherapy for dermatomycoses, subcutaneous and invasive mycoses is summarized, and open questions and unsolved problems are presented. The book is ideal for both the practitioner as well as advanced student.

Hydroxy-Pyridones as Antifungal Agents with Special Emphasis on Onychomycosis

Hydroxy-Pyridones as Antifungal Agents with Special Emphasis on Onychomycosis
  • Author : Sam Shuster
  • Publisher : Springer Science & Business Media
  • Release : 11 November 2013
GET THIS BOOKHydroxy-Pyridones as Antifungal Agents with Special Emphasis on Onychomycosis

This book summarizes the results of two symposia held on hydroxy-pyridones as antifungal agents organized on the occasion of the International Summit on Cutaneous Antifungal Therapy 1996 in Vancouver and the 19th World Congress of Dermatology 1997 in Sydney. Some of the papers deal with the basic mechanisms of action and how these translate into product features, e.g. activity spectrum. Other papers describe the unique properties of hydroxy-pyridones, such as high penetration into and through keratinic tissues or their activity as

Antifungal Agents

Antifungal Agents
  • Author : Ernst M. Jucker
  • Publisher : Birkhäuser
  • Release : 24 February 2003
GET THIS BOOKAntifungal Agents

This second volume of PDR SPECIAL TOPICS contains five review articles, covering nearly the entire field of fungal diseases in humans as well as therapeutic approaches. The main emphasis of the book lies in antifungal therapy: the most relevant information on the present state of the art of antifungal chemotherapy for dermatomycoses, subcutaneous and invasive mycoses is summarized, and open questions and unsolved problems are presented. The book is ideal for both the practitioner as well as advanced student.

Antifungal Agents

Antifungal Agents
  • Author : G. K. Dixon,Leonard G. Copping,Derek W. Hollomon
  • Publisher : Bios Scientific Pub Limited
  • Release : 30 November 1995
GET THIS BOOKAntifungal Agents

Explores how new molecular technologies are interfacing with chemistry and biology in the search for new fungicide targets.

Antifungal Agents

Antifungal Agents
  • Author : Erika J. Ernst,P. David Rogers
  • Publisher : Springer Science & Business Media
  • Release : 30 November 2021
GET THIS BOOKAntifungal Agents

A collection of state-of-the-art molecular methods for studying antifungal resistance, for discovering and evaluating both new and existing antifungal drugs, and for understanding the host response and immunotherapy of such agents. The protocols follow the successful Methods in Molecular MedicineTM series format, each offering step-by-step laboratory instructions, an introduction outlining the principle behind the technique, lists of the necessary equipment and reagents, and tips on troubleshooting and avoiding known pitfalls.

Interactions of Yeasts, Moulds, and Antifungal Agents

Interactions of Yeasts, Moulds, and Antifungal Agents
  • Author : Gerri S. Hall
  • Publisher : Springer Science & Business Media
  • Release : 02 December 2011
GET THIS BOOKInteractions of Yeasts, Moulds, and Antifungal Agents

The incidence of fungal infections increases with the increase in antibiotic usage and increasing immunosuppressed populations. There is no longer only one antifungal agent and the response of fungi to various agents is not always predictable. The need for standardized antifungal susceptibility testing, and standardized interpretation of results in conjunction with studies that describe clinical outcomes based on those tools is ever important. Interactions of Yeasts, Moulds, and Antifungal Agents: How to Detect Resistance covers the available antifungal agents, how

Recent Trends in Antifungal Agents and Antifungal Therapy

Recent Trends in Antifungal Agents and Antifungal Therapy
  • Author : Amit Basak,Ranadhir Chakraborty,Santi M. Mandal
  • Publisher : Springer
  • Release : 21 September 2016
GET THIS BOOKRecent Trends in Antifungal Agents and Antifungal Therapy

Fungal infections have taken a new spectrum due to the increased incidence of multi-drug resistant fungal pathogens. Freedom of choice for drugs to treat fungal infections is also narrow because of lesser probability of discovering drugs that would bypass affecting human cells and target fungal cells producing fewer side effects in patients. An approach has gained prominence in research is to look for bioactive antifungal compounds from natural to synthetic sources. It is necessary to discover new classes of antifungals

Interactions of Yeasts, Moulds, and Antifungal Agents

Interactions of Yeasts, Moulds, and Antifungal Agents
  • Author : Gerri S. Hall
  • Publisher : Humana Press
  • Release : 03 March 2014
GET THIS BOOKInteractions of Yeasts, Moulds, and Antifungal Agents

The incidence of fungal infections increases with the increase in antibiotic usage and increasing immunosuppressed populations. There is no longer only one antifungal agent and the response of fungi to various agents is not always predictable. The need for standardized antifungal susceptibility testing, and standardized interpretation of results in conjunction with studies that describe clinical outcomes based on those tools is ever important. Interactions of Yeasts, Moulds, and Antifungal Agents: How to Detect Resistance covers the available antifungal agents, how

Antifungal Drug Discovery: New Theories and New Therapies

Antifungal Drug Discovery: New Theories and New Therapies
  • Author : Chaminda Jayampath Seneviratne,Edvaldo Antonio Ribeiro Rosa
  • Publisher : Frontiers Media SA
  • Release : 13 September 2016
GET THIS BOOKAntifungal Drug Discovery: New Theories and New Therapies

Fungal infections such as candidoses can range from superficial mucous membrane infection to life-threatening systemic mycoses. Candida infections are a significant clinical problem globally due to rapid rise in compromised host populations including HIV/AIDS, organ transplant recipients and patients on chemotherapy. In addition, sharp increase in aging populations which are susceptible to fungal infections is expected in next few decades. Antifungal drugs are relatively difficult to develop compared to the antibacterial drugs owing to the eukaryotic nature of the

Comparison of Antifungal Activities of Efinaconazole and Conventional Antifungal Agents Against Dermatophytes and Yeasts

Comparison of Antifungal Activities of Efinaconazole and Conventional Antifungal Agents Against Dermatophytes and Yeasts
  • Author : Joo Ran Hong
  • Publisher : Unknown Publisher
  • Release : 30 November 2021
GET THIS BOOKComparison of Antifungal Activities of Efinaconazole and Conventional Antifungal Agents Against Dermatophytes and Yeasts

As growing the number of aging population and immunocompromised patients, there has been an increase in patients with skin fungal infections. Trichophyton rubrum, Trichophyton mentagrophytes and Candida albicans are known as the key pathogen of superficial dermatomycosis. Although itraconazole, terbinafine, amorolfine, and ciclopirox have been used for the treatment of these infections, they have limitation due to the drug side effects and lack of efficacy. In 2014, the Food and Drug Administration approved efinaconazole as a novel antifungals particular in onychomycosis.

Antifungal Agents

Antifungal Agents
  • Author : Erika J. Ernst
  • Publisher : Humana Press
  • Release : 16 May 2005
GET THIS BOOKAntifungal Agents

A collection of state-of-the-art molecular methods for studying antifungal resistance, for discovering and evaluating both new and existing antifungal drugs, and for understanding the host response and immunotherapy of such agents. The protocols follow the successful Methods in Molecular MedicineTM series format, each offering step-by-step laboratory instructions, an introduction outlining the principle behind the technique, lists of the necessary equipment and reagents, and tips on troubleshooting and avoiding known pitfalls. Antifungal Agents: Methods and Protocols offers clinician-scientists, microbiologists and molecular

Antifungal Compounds Discovery

Antifungal Compounds Discovery
  • Author : Marina Sokovic,Konstantinos Liaras
  • Publisher : Elsevier
  • Release : 18 September 2020
GET THIS BOOKAntifungal Compounds Discovery

Fungi are both the cause of many major health problems and an incredible source of compounds for developing new medicinal treatments, and with the increasing emergence of multidrug resistance, the need for new antimicrobial agents is greater than ever. Antifungal Compounds Discovery provides researchers with a detailed study of both natural and synthetic compounds that can be effective against a variety of fungal species, supporting and encouraging the design of innovative, potent new drug candidates for the treatment of fungal

Candida albicans: Cellular and Molecular Biology

Candida albicans: Cellular and Molecular Biology
  • Author : Rajendra Prasad
  • Publisher : Springer
  • Release : 31 January 2017
GET THIS BOOKCandida albicans: Cellular and Molecular Biology

This book on Candida albicans and similar pathogens provides a timely overview of the groundbreaking discoveries made in the areas of drug resistance, host–pathogen interactions, virulence, host immune system modulation, etc., in the last two decades. This comprehensive 2nd Edition includes chapters on fungal infections, hyphal morphogenesis, molecular mechanisms of antifungal resistance, antifungal agents, multidrug transporters, virulence mechanisms in Candida albicans, host–pathogen interactions, the cell wall, fungal biofilms, lipids and antifungal resistance, signaling mechanisms and last but not